2-(Nitrophenyl)adenine derivatives were isolated from the reaction of 5-amino-4amidino-imidazoles with nitro-benzaldehydes. The conversion of the nitro derivatives to 2-(aminophenyl)adenine derivatives was performed using iron/acetic acid as reducing agent, in 70% aqueous ethanol. The products were isolated in good yield and the isolation protocol involves simple filtration and extraction procedures. This methodology is compatible with the presence of functional groups such as amines, ethers, halofluorides and halochlorides.
D r a f t D r a f t D r a f t Introduction A broad scientific community remains interested in nucleobases, in particular purine derivatives, as these compounds exhibit a diverse biological activity that is closely related to the substituents in the central nucleus of the molecule. 1 In particular purine derivatives with a hydrogen atom or an alkyl group on N9 of the purine nucleus have received special attention. In recent years, our research group designed and prepared new 9-aryl and 9alkylpurine derivatives that showed high activity against Mycobacterium tuberculosis 2 and potential antipsychotic activity, 3 respectively and this boosted a new drug development program.
Many synthetic methodologies have been reported to incorporate several functional groups in the purine core 4 however, most of these methods use reagents that are typically expensive and/or environmentally hazardous. Our research group developed a mild, simple and inexpensive synthetic approach to purine derivatives having different substituents in N9, C2 and C6 and several alkyl and aryl groups, including phenolic groups, were regioselectively incorporated in N9 and C2. 2, 5 To the best of our knowledge, a simple, efficient, inexpensive, non-toxic synthetic route to obtain 2-(aminoaryl)-purines 4 has not yet been reported. Considering that arylamines are key intermediates and fundamental precursors in the synthesis of numerous pharmaceuticals, dyes, agricultural chemicals and polymers 6 these new hetero-arylamines may be of interest for a large research community.
In order to generate the target compounds 4 using the synthetic approach designed previously by our group, the reaction of the imidazole derivative 1 with the desired amino-arylaldehyde would lead directly to the compounds 4 (Scheme 1). However, 2-D r a f t 4 and 4-aminobenzaldehydes are too expensive and 3-aminobenzaldehyde is not even commercially available. Scheme 1. Synthetic approaches to prepare 2-(aminophenyl)adenine derivatives 4 from imidazoles 1.
To overcome these obstacles we considered using nitrobenzaldehydes 2, as an efficient and economically feasible approach to obtain 2-(aminophenyl)purines 4 upon reduction of the corresponding nitro derivative.
The literature reports different methodologies to perform nitro group reduction such as hydrogenations, metal dissolving and hydride transfer reductions, catalytic transfer hydrogenations and metal-free reductions. 7 However some shortcomings associated to these methodologies are the lack of chemoselectivity, the need for special high-pressure equipment, the use of flammable hydrogen gas, hazardous reagents, expensive metal complexes, extensive reaction times or laborious work up procedures. So, the use of simple and ecofriendly methods to perform this reduction in molecules with other groups susceptible to reduction, are always desired. As far as we know, the synthesis and reduction of 2-(nitroaryl)adenine derivatives 3 was never reported.
D r a f t D r a f t 6 reaction mixture occurred (table 1, entry 1). The reaction was repeated using triethylamine as base (table 1, entry 4) and was performed using the minimum amount of DMSO and an excess of triethylamine, at 80 o C. After 17.5 h, the product 3c was isolated in 62% yield. These reaction conditions were applied to the other derivatives 1a, 1c-1j and the corresponding products were isolated in moderate to excellent yield after 2 to 22 hours (table 1).
In order to establish the methodology to perform the nitro reduction, we selected compound 3a and different reaction conditions were tested ( Table 2 ). The reactions were monitored by TLC.
When compound 3a was treated with pentahydrate CuSO 4 (1.5 equiv.) and NaBH 4 (2.5 equiv.), either in a mixture of EtOH: EtOAc (2:1) or in DCM, at temperature between 19 -21 o C, no reaction was observed ( Table 2 , entries 1, 2). The reduction was then performed with tin (II) chloride (4.0 equiv.), combined with aqueous hydrochloric acid, in ethanol, at 65 o C, for 14.5h, following an experimental procedure previously described in the literature. 8 The product 4a was isolated but in very low yield ( Table 2 , entry 3). Iron powder was then considered for the reduction. In the first attempt (Table 2, entry 4) compound 3a was treated with iron powder in ethanol, at temperature between 19 -21 o C. After 5h, the 1 H NMR on the solid isolated showed that product 4a was the major component in a complex mixture. The reaction was repeated but acetic acid was added to the reaction mixture in a 70% aqueous ethanol solution. The mixture was refluxed and after 3.5 h the product 4a was isolated in 55% yield. In order to improve the experimental conditions, the reaction was repeated using 8 equiv. of iron powder and the reflux was maintained for 4.5h, until TLC showed absence of starting reagent. The product 4a was isolated in low yield ( Table   2 , entry 6). The reaction was repeated once again but using a volume of solvent enough D r a f t 7 to solubilize the starting purine ( Table 2, entry 7) . After 4h under reflux the product 4a was isolated in 87% yield. These results seem to indicate that the volume of solvent is critical for the success of the reaction. A detailed analysis of the reactions showed that a better yield was obtained when the reagent 3 was in solution. These reaction conditions were applied to the derivatives 3b -3j and the corresponding products 4 were isolated in very good to excellent yield after simple filtration and extraction procedures (Scheme 3, Table 3 ). 
Conclusions
In summary, we have successfully synthesized novel 2-(aminophenyl)adenine derivatives 4, from the corresponding 2-(nitrophenyl)adenine derivatives 3 using reaction conditions that avoid the use of flammable hydrogen gas or high-pressure equipment. The method is compatible with the presence of functional groups such as amines, ethers, halofluorides and halochlorides but hasn't been evaluated for bromo or iodo derivatives. Our protocol D r a f t involves predominantly ecofriendly reagents and solvents, simple procedures for the isolation of products and short reaction times. The products are generally isolated in high yields. The reported compounds are fundamental precursors for the generation of new adenine derivatives with biological activity that will be reported elsewhere.
Experimental
Melting points (mp, ˚C) were determined in a Gallenkamp apparatus and are uncorrected.
D r a f t
4-(2-(3-nitrophenyl)-9-phenyl-9H-purin-6-yl)morpholine (3a)
Compound 3a (0.75 g, 1.79 mmol, 93%) was obtained as a light-yellow solid from compound 1a (0.52 g, 1.93 mmol) with 1.1. equiv of 2a after 2h. Mp 185-187˚C. IR 153.1, 151.0, 148.0, 139.6, 134.8, 133.8, 130.0, 129.6, 127.8, 124.3, 123.4, 121.7, 119.1, 66.2, 45.5. Anal. Calcd for C 21 H 18 N 6 O 3 : C, 62.68; H, 4.50; N, 20.89; Found: C, 62.57; H, 4.51; N, 20 .87. (2-(4-nitrophenyl)-9-phenyl-9H-purin-6-yl) 
4-
morpholine (3b) D r a f t D r a f t
4-(9-(4-chlorophenyl)-2-(3-nitrophenyl)-9H-purin-6-yl)morpholine (3e)
Compound 3e (0.46 g, 1.04 mmol, 59%) was obtained as a yellow solid from compound 1d (0.54 g, 1.76 mmol) and 1 (8-C), 139. 7, 134.0, 133.7, 132.3, 131.2, 130.2, 129.6, 125.3, 124.6, 121.9, 119. 
4-(9-(3,4-dichlorophenyl)-2-(3-nitrophenyl)-9H-purin-6-yl)morpholine (3f)
4-(9-benzyl-2-(3-nitrophenyl)-9H-purin-6-yl)morpholine (3g)
Compound 3g (0.25 g, 0.60 mmol, 72%) was obtained as a light-beige solid from compound 1f (0.24 g, 0.83 mmol) and 1.1 equiv of 2a after 5h. 3, 151.7, 148.4, 140.1, 137.1, 134.1, 130.4, 129.0, 128.2, 128.1, 124.6, 122.0, 118.8, 66.5, 46.7, 45.6. Anal. Calcd for C 22 H 20 N 6 O 3 : C, 63.45; H, 4.84; N, 20.18; Found: C, 63.28; H, 4.82; N, 20 .09.
4-(2-(3-nitrophenyl)-9H-purin-6-yl)morpholine (3h)
Compound 3h (0.13 g, 0.38 mmol, 73%) was obtained as a tanned yellow solid from compound 1g (0.10 g, 0.52 mmol) and 1.1 equiv of 2a after 20h. Mp 258-260˚C. IR 7, 153.0, 152.4, 148.1, 139.4, 133.7, 130.1, 124.1, 121.7, 118.4, 66.2, 45.2. Anal. Calcd for C 15 H 14 N 6 O 3 : C, 55.21; H, 4.32; N, 25.76. Found: C, 55.03; H, 4.02; N, 25.82 (9-(3,4-dichlorophenyl)-6-morpholino-9H-purin-2-yl) 4, 153.1, 151.3, 148.7, 138.8 (8-C), 138.5, 135.0, 131.9, 131.3, 129.7, 128.7, 124.53, 123.0, 118.5, 115.8, 115.8, 113.5, 66.3, 45 .1. Anal. Calcd for C 21 H 18 Cl 2 N 6 O: C, 57.15; H, 4.11; N, 19.04. Found: C, 57.32; H, 4.04; N, 18 .87.
3-(6-morpholino-9H-purin-2-yl)aniline (4g)
Compound 4g (0.16 g, 0.54 mmol, 82%) was obtained as a brownish solid from 3, 153.1, 151.4, 148.5, 139.0, 135.3, 129.6, 128.6, 127.5, 118.4, 115.9, 115.7, 113.5, 45.8, 25.8, 24.4. Anal. Calcd for C 22 H 22 N 6 : C, 71.33; H, 5.98; N, 22.69. Found: C, 71.15; H, 5.95; N, 22.73 . D r a f t D r a f t 
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